Indian drugmaker Cipla Limited has entered into a strategic marketing and distribution agreement with US pharma major Eli ...

The company is banking on key new launches, including weight loss drug Semaglutide and biosimilar Abatacept to drive growth ...

Welcome to NDTV Profit's live coverage of the Indian equity markets. Here we bring you real-time updates, sharp analyst ...

From generics glory to a billion-dollar dream of discovery, how Dr. Anji Reddy’s audacious vision reshaped Indian pharma—and ...

Tata Capital, Maruti Suzuki India, Urban Company, NTPC, Bank of Baroda and Cipla are among over 300 companies scheduled to ...

Dr Reddy's Laboratories has received approval to manufacture and market generic semaglutide, a weight loss drug, once Novo Nordisk's patent expires in 2026.

Mid-week on Wednesday, October 29th, attention will turn to public sector behemoths Coal India Ltd and Steel Authority of India Ltd (SAIL).

Earnings calendar for Oct 25-31 highlights Nifty giants like Kotak Mahindra Bank, L&T, ITC, Maruti Suzuki, and dozens of ...

Britain's Medicines and Healthcare products Regulatory Agency seized a large cache of unlicensed weight-loss drugs, including ...

The delegation, led by German Consul General Achim Burkart, described the relationship as a "win-win situation" for both sides. Speaking to ANI on Friday, Burkart said the visit aimed to deepen ...

They have dismantled a factory that made injections labelled as containing tirzepatide, the ingredient in Eli Lilly's ...

Eli Lilly and Co. has reached an agreement with pharmaceutical Cipla to market tirzepatide, the active ingredient in Lilly’s ...